| 1 |
33756436 | Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis. | 2021 Jul |
7 |
| 2 |
34218210 | Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis. | 2021 Oct |
5 |
| 3 |
34411648 | ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. | 2021 Dec 30 |
3 |
| 4 |
34612084 | Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. | 2021 Oct |
2 |
| 5 |
30835363 | [Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy]. | 2019 Mar 10 |
3 |
| 6 |
30538486 | The possible effect of SCN1A and SCN2A genetic variants on carbamazepine response among Khyber Pakhtunkhwa epileptic patients, Pakistan. | 2018 |
8 |
| 7 |
28199897 | Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy. | 2017 Mar |
1 |
| 8 |
26183863 | Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes. | 2016 Jan |
1 |
| 9 |
26314341 | Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy. | 2015 |
3 |
| 10 |
26555147 | Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients. | 2015 |
1 |
| 11 |
26877851 | SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients. | 2015 Dec |
3 |
| 12 |
24417206 | A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study. | 2014 Feb |
1 |
| 13 |
24861996 | Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. | 2014 Aug |
1 |
| 14 |
24921390 | Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients. | 2014 May |
3 |
| 15 |
25155934 | Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. | 2014 Jul |
2 |
| 16 |
22188362 | Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. | 2012 Jan |
5 |
| 17 |
22292851 | Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population. | 2012 Apr |
4 |
| 18 |
22591328 | Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up. | 2012 Jul |
3 |
| 19 |
24052718 | Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy. | 2012 Jun |
1 |
| 20 |
21453355 | SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs. | 2011 May |
1 |
| 21 |
21561445 | A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. | 2011 May |
1 |
| 22 |
18489610 | Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. | 2008 Aug |
3 |
| 23 |
15805193 | Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. | 2005 Apr 12 |
1 |